FEMY Femasys Inc.

2.000USD-3.85%Mkt Cap: 16.75M $P/E: —

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratub…

Key Statistics

Company
Market Cap16.75M USD
Enterprise Value20.77M USD
Revenue (TTM)2.30M USD
Gross Profit1.42M USD
Net Income (TTM)-18.63M USD
Revenue/Share0.77 USD
Last Price2.000 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees51
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.98
PEG—
EV/EBITDA-1.21
EV/Revenue9.03
P/S7.58
P/B1.56
EPS (TTM)-3.28
EPS (Forward)-2.13
52W Range
1.9600% of range22.20
52W High22.20 USD
52W Low1.960 USD
Profitability
Gross Margin61.96%
Oper. Margin-1526.66%
EBITDA Margin0.00%
Profit Margin-812.27%
ROE-317.38%
ROA-89.88%
Growth
Revenue Growth-18.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.69M USD
CapEx (TTM)630.10K USD
FCF Margin-488.37%
FCF Yield-67.04%
Net Debt3.35M USD
Net Debt/EBITDA-0.19
Balance Sheet
Debt/Equity0.80
Current Ratio2.14
Quick Ratio0.41
Book Value/Sh1.33 USD
Cash/Share0.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 8, 2026
Analyst Consensus
Rating—
Target (Mean)14.33 USD
Upside (mean)+616.7%
Target Range10.00 USD – 23.00 USD
10.00+616.7% to mean23.00
# Analysts3
Ownership
Shares Out.8.38M
Float7.35M
Insiders3.92%
Institutions47.26%
Short Interest
Short Ratio0.3d
Short % Float7.44%
Short % Out.7.31%
Shares Short612.62K
Short (prev mo.)435.00K
Technical
SMA 502.669 (-25.1%)
SMA 2007.246 (-72.4%)
Beta-2.15
S&P 52W Chg16.45%
Avg Vol (30d)1.35M
Avg Vol (10d)119.23K
Technical Indicators
RSI (14)32.0
MACD-0.2366
MACD Signal-0.2079
MACD Hist.-0.0287
BB Upper2.979 USD
BB Middle2.416 USD
BB Lower1.852 USD
BB Width46.66%
ATR (14)0.2183 USD
Vol Ratio (20d)0.91x